Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (93)

« Back to Publications

Population pharmacokinetics of artemether-lumefantrine plus amodiaquine in patients with uncomplicated Plasmodium falciparum malaria.

Ding J. et al, (2026), Br J Clin Pharmacol, 92, 589 - 605

Model-guided geospatial surveillance system for antimalarial drug resistance.

Gupta A. et al, (2026), PLOS Glob Public Health, 6

Adaptive Geospatial Surveillance System for Antimalarial Drug Resistance

Gupta A. et al, (2025)

Regional action needed to halt antimalarial drug resistance in Africa.

Martinez-Vega R. et al, (2025), Lancet, 405, 7 - 10

Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.

Schilling WHK. et al, (2024), PLoS Med, 21

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.

Taylor WRJ. et al, (2023), PLoS Negl Trop Dis, 17

Making data map-worthy-enhancing routine malaria data to support surveillance and mapping of Plasmodium falciparum anti-malarial resistance in a pre-elimination sub-Saharan African setting: a molecular and spatiotemporal epidemiology study.

Kagoro FM. et al, (2022), Malar J, 21

Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning.

Das D. et al, (2022), Malar J, 21

Molecular surveillance for operationally relevant genetic polymorphisms in Plasmodium falciparum in Southern Chad, 2016-2017.

Das S. et al, (2022), Malar J, 21

Boosting the impact of seasonal malaria chemoprevention (SMC) through simultaneous screening and treatment of household members of children receiving SMC in Burkina Faso: a protocol for a randomized open label trial.

Sondo P. et al, (2022), Arch Public Health, 80

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria.

Tindana P. et al, (2022), PLoS One, 17

Highlights 2020: framing health stories.

Palmer J. and Highlights 2020 winning contributors ., (2021), Lancet, 396, 1957 - 1971

Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion.

Imwong M. et al, (2021), Antimicrob Agents Chemother, 65

Arterolane-piperaquine-mefloquine versus arterolane-piperaquine and artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial.

Hamaluba M. et al, (2021), Lancet Infect Dis, 21, 1395 - 1406

Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination.

Dhorda M. et al, (2021), Curr Opin Infect Dis, 34, 432 - 439

Load More

1
2
3
4
5
6
7